Parkinson’s disease, a progressively debilitating neurological condition affecting about 1 million people in the United States, is caused by the loss of dopamine-producing neurons. Currently, researchers are seeking
(HealthDay)—A sensor array has the potential to identify de novo Parkinson’s disease (PD) patients with high sensitivity, specificity, and accuracy values, according to a research letter published online
Many with Parkinson’s disease are given a diagnosis in advanced stages of the disease. A new breathalyzer test could potentially change the way Parkinson’s disease is diagnosed and
The best-known treatment for Parkinson’s disease isn’t perfect. Named levodopa, the drug can treat the stiffness and slowness of movement associated with the debilitating disease. “The problem is
Researchers from Case Western Reserve University School of Medicine have found a nanobody that holds promise to advance targeted therapies for a number of neurological diseases and cancer.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
